https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01586-0/fulltext
0
0
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: a - The Lancet
10/9/22 at 4:20am
Organization
The Lancet
Authors
Details
79 words
Summarize
Health community-dwelling SARS-CoV HK The Lancet COVID Omicron Nirmatrelvir
During Hong Kong's wave of SARS-CoV-2 omicron subvariant BA.2.2, among non-hospitalised patients with COVID-19, early initiation of novel oral antivirals was associated with reduced risks of mortality and in-hospital disease progression. Nirmatrelvir plus rit…
Create an account or login to join the discussion